Drug-induced dystonia

Handbook of Dystonia

Volumn , Issue , 2006, Pages 267-276

  Cardoso, Francisco ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 41249085543     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (67)

1. Cardoso F, Jankovic J. Movement disorders. Neurol Clin 1993; 11(3): 625-638.
2. Cardoso FE, Jankovic J. Cocaine-related movement disorders. Mov Disord 1993; 8(2): 175-178.
3. Keepers GA, Clappison VJ, Casey DE. Initial anticholinergic prophylaxis for neurolepticinduced extrapyramidal syndromes. Arch Gen Psychiatry 1983; 40: 1113-1117.
4. Keepers GA, Casey DE. Prediction of neuroleptic-induced dystonia. J Clin Psychopharmacol 1987; 7: 342-344.
5. Marsden CD, Jenner P. The pathophysiology of extrapyramidal side-effects of neuroleptic drugs. Psychol Med 1980; 10: 55-72.
6. Muscettola G, Barbato G, Pampallona S, et al. Extrapyramidal syndromes in neuroleptictreated patients: prevalence, risk factors, and association with tardive dyskinesia. J Clin Psychopharmacol 1999; 19(3): 203-208.
7. Alevizos B, Papageorgiou C, Christodoulou GN. Acute dystonia caused by low dosage of olanzapine. J Neuropsychiatry Clin Neurosci 2003; 15(2): 241.
8. Coffey GL, Botts SR, de Leon J. High vulnerability to acute dystonic reactions: a case of antipsychotic exposure and uncontrolled seizure activity. Prog Neuropsychopharmacol Biol Psychiatry 2005; 29(5): 770-774.
9. Kastrup O, Gastpar M, Schwarz M. Acute dystonia due to clozapine. J Neurol Neurosurg Psychiatry 1994; 57: 119.
10. Jankovic J. Treatment of hyperkinetic movement disorders with tetrabenazine: a doubleblind crossover study. Ann Neurol 1982; 11: 41-47.
11. Burke RE, Reches A, Traub MM, et al. Tetrabenazine induces acute dystonic reactions. Ann Neurol 1985; 17(2): 200-202.
12. Ganzini L, Casey DE, Hoffman WF, McCall AL. The prevalence of metoclopramideinduced tardive dyskinesia and acute extrapyramidal movement disorders. Arch Intern Med 1993; 153(12): 1469-1475.
13. Burke RE, Fahn S, Jankovic J, et al. Tardive dystonia and inappropriate use of neuroleptic drugs. Lancet 1982; 1(8284): 1299.
14. Burke RE, Fahn S, Jankovic J, et al. Tardive dystonia: late-onset and persistent dystonia caused by antipsychotic drugs. Neurology 1982; 32(12): 1335-1346.
15. Yassa R, Nair V, Dimitry R. Prevalence of tardive dystonia. Acta Psychiatr Scand 1986; 73(6): 629-633.
16. Friedman JH, Kucharski LT, Wagner RL. Tardive dystonia in a psychiatric hospital. J Neurol Neurosurg Psychiatry 1987; 50(6): 801-803.
17. Sethi KD, Hess DC, Harp RJ. Prevalence of dystonia in veterans on chronic antipsychotic therapy. Mov Disord 1990; 5(4): 319-321.
18. van Harten PN, Matroos GE, Hoek HW, Kahn RS. The prevalence of tardive dystonia, tardive dyskinesia, parkinsonism and akathisia the curacao extrapyramidal syndromes study: I. Schizophr Res 1996; 19(2-3): 195-203.
19. Gimenez-Roldan S, Mateo D, Bartolome P. Tardive dystonia and severe tardive dyskinesia. A comparison of risk factors and prognosis. Acta Psychiatr Scand 1985; 71(5): 488-494.
20. Sachdev P. Risk factors for tardive dystonia: a case-control comparison with tardive dyskinesia. Acta Psychiatr Scand 1993; 88(2): 98-103.
21. Raja M, Azzoni A. Tardive dystonia. Prevalence, risk factors and clinical features. Ital J Neurol Sci 1996; 17(6): 409-418.
22. Kiriakakis V, Bhatia KP, Quinn NP, Marsden CD. The natural history of tardive dystonia. A long-term follow-up study of 107 cases. Brain 1998; 121(Pt 11): 2053-2066.
23. Wonodi I, Adami HM, Cassady SL, et al. Ethnicity and the course of tardive dyskinesia in outpatients presenting to the motor disorders clinic at the Maryland psychiatric research center. J Clin Psychopharmacol 2004; 24(6): 592-598.
24. Clark LT. Issues in minority health: atherosclerosis and coronary heart disease in African Americans. Med Clin North Am 2005; 89(5): 977-1001.
25. Miller LG, Jankovic J. Sulpiride-induced tardive dystonia. Mov Disord 1990; 5(1): 83-84.
26. Vercueil L, Foucher J. Risperidone-induced tardive dystonia and psychosis. Lancet 1999; 20353(9157): 981.
27. Dunayevich E, Strakowski SM. Olanzapine-induced tardive dystonia. Am J Psychiatry 1999; 156(10): 1662.
28. Stacy M, Cardoso F, Jankovic J. Tardive stereotypy and other movement disorders in tardive dyskinesias. Neurology 1993; 43(5): 937-941.
29. Chouza C, Scaramelli A, Caamano JL, et al. Parkinsonism, tardive dyskinesia, akathisia, and depression induced by flunarizine. Lancet 1986; 1(8493): 1303-1304.
30. Barbosa MT, Caramelli P, Maia DP, et al. Parkinsonism and Parkinson’s disease in the elderly: a community-based survey in Brazil (The Bambuí study). Mov Disord 2006; 21(6): 800-808.
31. Le Witt PA, Walters A, Hening W, McHale D. Persistent movement disorders induced by buspirone. Mov Disord 1993; 8(3): 331-334.
32. Ghadirian AM, Annable L, Belanger MC, Chouinard G. A cross-sectional study of parkinsonism and tardive dyskinesia in lithium-treated affective disordered patients. J Clin Psychiatry 1996; 57(1): 22-28.
33. Chakrabarti S, Chand PK. Lithium - induced tardive dystonia. Neurol India 2002; 50(4): 473-475.
34. Leo RJ. Movement disorders associated with the serotonin selective reuptake inhibitors. J Clin Psychiatry 1996; 57(10): 449-454.
35. Vandel P, Bonin B, Leveque E, et al. Tricyclic antidepressant-induced extrapyramidal side effects. Eur Neuropsychopharmacol 1997; 7(3): 207-212.
36. Calabresi P, De Murtas M, Mercuri NB, et al. Chronic neuroleptic treatment: D2 dopamine receptor supersensitivity and striatal glutamatergic transmission. Ann Neurol 1992; 31: 366-373.
37. Cardoso F, Jankovic J. Dystonia and dyskinesia. Psychiatr Clin North America 1997; 20(4): 821-838.
38. Cross AJ, Crow TJ, Ferrier IN, et al. Chemical and structural changes in the brain in patients with movement disorder. In: Casey DE, Chase TN, Chritine AV, Gerlach J, eds. Dyskinesia: Research and Treatment. New York: Springer-Verlag, 1985: 104-110.
39. Gerlach J. Current views on tardive dyskinesia. Pharmacopsychiatry 1991; 27: 47-48.
40. Casey DE. Pathophysiology of antipsychotic drug-induced movement disorders. J Clin Psychiatry 2004; 65(Suppl 9): 25-28.
41. Mitchell IJ, Crossman AR, Liminga U, et al. Regional changes in 2-deoxyglucose uptake associated with neurleptic-induced tardive dyskinesia in the Cebus monkey. Mov Disord 1992; 7: 32-37.
42. Gunne LM, Haggstrom JE, Sjoquist B. Association with persistent neuroleptic-induced dyskinesia of regional changes in brain GABA synthesis. Nature 1984; 309: 347-349.
43. Bressman SB, de Leon D, Raymond D, et al. Secondary dystonia and the DYTI gene. Neurology 1997; 48(6): 1571-1577.
44. Mihara K, Kondo T, Higuchi H, et al. Tardive dystonia and genetic polymorphisms of cytochrome P4502D6 and dopamine D2 and D3 receptors: a preliminary finding. Am J Med Genet 2002; 114(6): 693-695.
45. Kaiser R, Tremblay PB, Klufmoller F, Roots I, Brockmoller J. Relationship between adverse effects of antipsychotic treatment and dopamine D(2) receptor polymorphisms in patients with schizophrenia. Mol Psychiatry 2002; 7(7): 695-705.
46. Kang UJ, Burke RE, Fahn S. Natural history and treatment of tardive dystonia. Mov Disord 1986; 1(3): 193-208.
47. Tan EK, Jankovic J. Tardive and idiopathic oromandibular dystonia: a clinical comparison. J Neurol Neurosurg Psychiatry 2000; 68(2): 186-190.
48. Molho ES, Feustel PJ, Factor SA. Clinical comparison of tardive and idiopathic cervical dystonia. Mov Disord 1998; 13(3): 486-489.
49. Konrad C, Vollmer-Haase J, Gaubitz M, et al. Fracture of the odontoid process complicating tardive dystonia. Mov Disord 2004; 19(8): 983-985.
50. Hacking D, Werring DJ. Bilateral first rib fractures due to tardive dystonia. J Neurol Neurosurg Psychiatry 2005; 76(7): 983.
51. Achiron A, Melamed E. Tardive eating dystonia. Mov Disord 1990; 5(4): 331-333.
52. Ford B, Greene P, Fahn S. Oral and genital tardive pain syndromes. Neurology 1994; 44(11): 2115-2119.
53. Paleacu D, Giladi N, Moore O, et al. Tetrabenazine treatment in movement disorders. Clin Neuropharmacol 2004; 27(5): 230-233.
54. Lucetti C, Bellini G, Nuti A, et al. Treatment of patients with tardive dystonia with olanzapine. Clin Neuropharmacol 2002; 25(2): 71-74.
55. Bai YM, Yu SC, Chen JY, et al. Risperidone for pre-existing severe tardive dyskinesia: a 48-week prospective follow-up study. Int Clin Psychopharmacol 2005; 20(2): 79-85.
56. Gourzis P, Polychronopoulos P, Papapetropoulos S, et al. Quetiapine in the treatment of focal tardive dystonia induced by other atypical antipsychotics: A report of 2 cases. Clin Neuropharmacol 2005; 28(4): 195-196.
57. Friedman JH. Clozapine treatment of psychosis in patients with tardive dystonia: report of three cases. Mov Disord 1994; 9(3): 321-324.
58. Trugman JM, Leadbetter R, Zalis ME, et al. Treatment of severe axial tardive dystonia with clozapine: case report and hypothesis. Mov Disord 1994; 9(4): 441-446.
59. Adityanjee, Estrera AB. Successful treatment of tardive dystonia with clozapine. Biol Psychiatry 1996; 39(12): 1064-1065.
60. Karp BI, Goldstein SR, Chen R, et al. An open trial of clozapine for dystonia. Mov Disord 1999; 14(4): 652-657.
61. Brashear A, Ambrosius WT, Eckert GJ, Siemers ER. Comparison of treatment of tardive dystonia and idiopathic cervical dystonia with botulinum toxin type A. Mov Disord 1998; 13(1): 158-161.
62. Comella CL, Shannon KM, Jaglin J. Extensor truncal dystonia: successful treatment with botulinum toxin injections. Mov Disord 1998; 13(3): 552-555.
63. Cardoso F. Botulinum toxin type B in the management of dystonia non-responsive to botulinum toxin type A. Arq Neuropsiquiatr 2003; 61(3A): 607-610.
64. Dressler D, Oeljeschlager RO, Ruther E. Severe tardive dystonia: treatment with continuous intrathecal baclofen administration. Mov Disord 1997; 12(4): 585-587.
65. Krause M, Fogel W, Kloss M, et al. Pallidal stimulation for dystonia. Neurosurgery 2004; 55(6): 1361-1368.
66. Starr PA, Turner RS, Rau G, et al. Microelectrode-guided implantation of deep brain stimulators into the globus pallidus internus for dystonia: techniques, electrode locations, and outcomes. Neurosurg Focus 2004; 17(1): E4.
67. Trottenberg T, Volkmann J, Deuschl G, et al. Treatment of severe tardive dystonia with pallidal deep brain stimulation. Neurology 2005; 64(2): 344-346.